Javascript must be enabled to continue!
Variation in levels of AMH among Maya and non‐Maya women in Campeche, Mexico
View through CrossRef
AbstractObjectivesThe purpose of this study was to examine anti‐Müllerian hormone (AMH) levels among women of Maya and non‐Maya ancestry in the city of Campeche, Mexico. Levels of AMH can potentially predict age at menopause. Previous studies have indicated an early mean age at menopause among the Maya.Materials and methodsWomen aged 40‐60 (n = 97) participated in semistructured interviews, anthropometric measures, and blood samples. Maya/non‐Maya ethnicity was determined by the last names, languages spoken, and birthplace of the woman, her parents, and her grandparents. AMH values were categorized as detectable (0.05‐4.19 ng/mL) and undetectable (<0.05 ng/mL). Logistic regressions calculated odds ratios (OR) for undetectable AMH.ResultsWomen were categorized as Maya (n = 44), not Maya (n = 39), or not able to be clearly defined (n = 14). In bivariate comparisons, women with detectable levels of AMH were younger, more likely to be pre‐menopausal, and not Maya. Age, menopausal status, and ethnicity remained significant in a logistic regression models after controlling for age at menarche. Maya women were more than five times as likely to have nondetectable AMH levels as non‐Maya women.DiscussionIncreasing age and progression through the menopausal transition were both associated with declining levels of AMH. The association between Maya ethnicity and a lower likelihood of detecting AMH is consistent with the early ages at menopause reported in previous studies. We considered a rapid life history model as an explanatory framework, and suggest, from an ecological perspective, that future research should consider measures of developmental stress that may compromise ovarian reserves.
Title: Variation in levels of AMH among Maya and non‐Maya women in Campeche, Mexico
Description:
AbstractObjectivesThe purpose of this study was to examine anti‐Müllerian hormone (AMH) levels among women of Maya and non‐Maya ancestry in the city of Campeche, Mexico.
Levels of AMH can potentially predict age at menopause.
Previous studies have indicated an early mean age at menopause among the Maya.
Materials and methodsWomen aged 40‐60 (n = 97) participated in semistructured interviews, anthropometric measures, and blood samples.
Maya/non‐Maya ethnicity was determined by the last names, languages spoken, and birthplace of the woman, her parents, and her grandparents.
AMH values were categorized as detectable (0.
05‐4.
19 ng/mL) and undetectable (<0.
05 ng/mL).
Logistic regressions calculated odds ratios (OR) for undetectable AMH.
ResultsWomen were categorized as Maya (n = 44), not Maya (n = 39), or not able to be clearly defined (n = 14).
In bivariate comparisons, women with detectable levels of AMH were younger, more likely to be pre‐menopausal, and not Maya.
Age, menopausal status, and ethnicity remained significant in a logistic regression models after controlling for age at menarche.
Maya women were more than five times as likely to have nondetectable AMH levels as non‐Maya women.
DiscussionIncreasing age and progression through the menopausal transition were both associated with declining levels of AMH.
The association between Maya ethnicity and a lower likelihood of detecting AMH is consistent with the early ages at menopause reported in previous studies.
We considered a rapid life history model as an explanatory framework, and suggest, from an ecological perspective, that future research should consider measures of developmental stress that may compromise ovarian reserves.
Related Results
P-695 Anti-muellerian Hormone (AMH) and Plasminogen Activator Inhibitor (PAI-1) are robust follicular-fluid (FF) biomarkers predictive of follicle maturity and oocyte quality in women undergoing IVF cycles
P-695 Anti-muellerian Hormone (AMH) and Plasminogen Activator Inhibitor (PAI-1) are robust follicular-fluid (FF) biomarkers predictive of follicle maturity and oocyte quality in women undergoing IVF cycles
Abstract
Study question
Is AMH the in-vivo trigger that correlates with PAI-1 in the follicular-fluid micro-milieu to influence ...
SUN-021 Age-Specific Multiples of the Median Level of Serum Anti-Mullerian Hormone Is a Potential Marker for Diagnosis of Polycystic Ovary Syndrome
SUN-021 Age-Specific Multiples of the Median Level of Serum Anti-Mullerian Hormone Is a Potential Marker for Diagnosis of Polycystic Ovary Syndrome
Abstract
Serum anti-Mullerian hormone (AMH) levels are significantly higher in women with polycystic ovary syndrome (PCOS) than in normal ovulatory women. Different ...
Live birth rate after IVF/ICSI in women with low and extremely low AMH: an age-matched controlled study
Live birth rate after IVF/ICSI in women with low and extremely low AMH: an age-matched controlled study
Abstract
Background
An age-matched controlled study, to assess the outcome of IVF/ICSI in low and extremely low AMH levels in different age groups by comparing the live birth rate
...
Serum anti-Müllerian hormone (AMH) levels correlate with infrarenal aortic diameter in healthy older men: is AMH a cardiovascular hormone?
Serum anti-Müllerian hormone (AMH) levels correlate with infrarenal aortic diameter in healthy older men: is AMH a cardiovascular hormone?
Anti-Müllerian hormone (AMH) is a gonadal hormone present in the blood in men and pre-menopausal women. AMH regulates male sexual differentiation but has no putative function in ad...
Is there a relationship between anti-Mullerian hormone (AMH) levels and the prediction of ovarian reserve in reproductive-age women undergoing fertility evaluation? : A Systematic Review
Is there a relationship between anti-Mullerian hormone (AMH) levels and the prediction of ovarian reserve in reproductive-age women undergoing fertility evaluation? : A Systematic Review
Introduction: Accurate assessment of ovarian reserve is crucial for counseling women undergoing fertility evaluation. Anti-Müllerian hormone (AMH) has emerged as a promising biomar...
Comparison between antral follicle count and anti-Müllerian hormonal level in the prediction of ovarian response and pregnancy outcome in intracytoplasmic sperm injection patients: implications in personalizing ovarian stimulation
Comparison between antral follicle count and anti-Müllerian hormonal level in the prediction of ovarian response and pregnancy outcome in intracytoplasmic sperm injection patients: implications in personalizing ovarian stimulation
Antral follicle count (AFC) and anti-Müllerian Hormone (AMH) are considered the best markers of ovarian reserve and ovarian response to stimulation. It is not clear whether they co...
Women in Australian Politics: Maintaining the Rage against the Political Machine
Women in Australian Politics: Maintaining the Rage against the Political Machine
Women in federal politics are under-represented today and always have been. At no time in the history of the federal parliament have women achieved equal representation with men. T...
Anti-Mullerian Hormone (AMH) as a Predictor of Ovarian Response to Clomiphene Citrate in Polycystic Ovarian Syndrome
Anti-Mullerian Hormone (AMH) as a Predictor of Ovarian Response to Clomiphene Citrate in Polycystic Ovarian Syndrome
Background: Serum Anti-Mullerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS) are two- to threefold higher than in ovulatory women with normal ovaries, corre...

